Difficulty: Medium
Average Score: 68%
Practice
Which of the following antianginal drugs is most likely to produce tachycardia as a side effect?
Correct answer
B
Rationale
In the context of pharmacology of cardiovascular drugs, understanding the specific mechanisms of action of each drug class is crucial to predict their potential side effects. In this case, the correct answer is B) Nifedipine, as it belongs to the dihydropyridine calcium channel blockers (CCBs) class. Nifedipine primarily acts on vascular smooth muscle to cause vasodilation, but it can also lead to reflex tachycardia due to its potent vasodilatory effects. This reflex tachycardia is a compensatory response by the body to maintain cardiac output in the face of decreased systemic vascular resistance.
A) Amlodipine is also a dihydropyridine CCB like nifedipine, but it is less likely to induce reflex tachycardia compared to nifedipine due to its longer duration of action and smoother pharmacokinetic profile.
C) Diltiazem and D) Verapamil are non-dihydropyridine CCBs. These drugs primarily act on the myocardium to decrease cardiac contractility and heart rate. They are more likely to cause bradycardia rather than tachycardia as a side effect.
Educationally, this question highlights the importance of recognizing the different subtypes of calcium channel blockers and their specific effects on the cardiovascular system. It underscores the need for healthcare professionals to be aware of potential side effects associated with different antianginal drugs to make informed clinical decisions and provide safe and effective patient care. Understanding these nuances can help in optimizing therapy and managing adverse effects in patients with cardiovascular conditions.
A) Amlodipine is also a dihydropyridine CCB like nifedipine, but it is less likely to induce reflex tachycardia compared to nifedipine due to its longer duration of action and smoother pharmacokinetic profile.
C) Diltiazem and D) Verapamil are non-dihydropyridine CCBs. These drugs primarily act on the myocardium to decrease cardiac contractility and heart rate. They are more likely to cause bradycardia rather than tachycardia as a side effect.
Educationally, this question highlights the importance of recognizing the different subtypes of calcium channel blockers and their specific effects on the cardiovascular system. It underscores the need for healthcare professionals to be aware of potential side effects associated with different antianginal drugs to make informed clinical decisions and provide safe and effective patient care. Understanding these nuances can help in optimizing therapy and managing adverse effects in patients with cardiovascular conditions.